07:59 EDT Legend Biotech files automatic mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LEGN:
- Legend Biotech price target raised to $81 from $76 at UBS
- Legend Biotech notes ODAC recommends Carvykti for earlier treatment of myeloma
- Legend Biotech initiated with an Outperform at Raymond James
- Legend Biotech reports Q4 EPS (40c), consensus (83c)
- LEGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?